Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/1471-2334-14-S2-P83
Published Online: 2014-05-23
Published Print: 2014-05
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Chantry, AS
Tching-Sin, M
Dhiver, C
Allegre, T
Ruiz, JM
Assi, A
Botta-Fridlund, D
Halfon, P
Faucher-Zaegel, O
Solas, C
Article History
First Online: 23 May 2014